A- A A+

„Infektionen und Gesellschaft – Was haben wir von COVID-19 gelernt?“

Herausgeber: Ansgar W. Lohse, Thomas C. Mettenleiter 

Verlag: Springer-Verlag Berlin Heidelberg

ISBN 978-3-662-66072-0 Hardcover für 53,49 €. eBook, kostenfrei als Open Access unter


Increased alcohol-specific mortality in Germany during COVID-19: State-level trends from 2010 to 2020.

Kilian, C, Carr, S, Schulte, B, Manthey, J.

Drug Alcohol Rev. 2022. doi.org/10.1111/dar.13573


Trajectories of resilience and mental distress to global major disruptions. 

Schäfer SK, Kunzler AM, Kalisch R, Tüscher O, Lieb K. 

Trends Cogn Sci. 2022 Dec;26(12):1171-1189. doi: 10.1016/j.tics.2022.09.017. Epub 2022 Oct 24. PMID: 36302711; PMCID: PMC9595401.


Changes in Alcohol-Related Behaviors and Quality of Life During the COVID-19 Pandemic: Impact of Alcohol Use Disorder Diagnosis and Treatment History. 

Luk JW, Stangl BL, Gunawan T, Schwandt ML, Morris JK, Axelowitz JC, Chawla S, Lee BA, Carraco M, Walsh S, McDuffie C, Agarwal K, Joseph PV, Momenan R, Goldman D, Diazgranados N, Ramchandani VA. 

J Clin Psychiatry. 2022 Nov 7;84(1):22br14462. doi: 10.4088/JCP.22br14462. PMID: 36350598.


Understanding the impact of the COVID-19 pandemic on substance use and HIV. 

Chandler R, Varthakavi V. 

Drug Alcohol Depend. 2022 Nov 5:109688. doi: 10.1016/j.drugalcdep.2022.109688. Epub ahead of print. PMID: 36371282; PMCID: PMC9636599.


Alcohol use during COVID-19 pandemic on the long run: findings from a longitudinal study in Germany. 

Schecke H, Bohn A, Scherbaum N, Mette C. 

BMC Psychol. 2022 Nov 14;10(1):266. doi: 10.1186/s40359-022-00965-8. PMID: 36376933; PMCID: PMC9661459.


Living evidence base for Cochrane Review “Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19.

Reis, S., Metzendorf, M.-I., Kuehn, R., Popp, M., Gágyor, I., Kranke, P., … Weibel, S. (2022, November 21). 

Cochrane Database of Systematic Reviews. doi.org/10.17605/OSF.IO/7G49C


Paxlovid: Deutschsprachige Checkliste unterstützt Anwendung

Berlin − Eine seit Kurzem verfügbare deutschsprachige Online-Checkliste soll den Einsatz des Kombinationspräparats Paxlovid (Nirmatrelvir/Ritonavir, Pfizer) bei SARS-CoV-2-Infektionen erleichtern. So bildet sie mögliche Wechselwirkungen des Medikaments ausführlich ab. Herausgeber der Checkliste ist die Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN). (aerzteblatt.de, 15.11.2022)


COVID-19 Drug Interactions (checker)

University of Liverpoll, UK, 2022


A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic. 

Bradley H, Austin C, Allen ST, Asher A, Bartholomew TS, Board A, Borquez A, Buchacz K, Carter A, Cooper HLF, Feinberg J, Furukawa N, Genberg B, Gorbach PM, Hagan H, Huriaux E, Hurley H, Luisi N, Martin NK, Rosenberg ES, Strathdee SA, Jarlais DCD. 

Int J Drug Policy. 2022 Oct 17;110:103889. doi: 10.1016/j.drugpo.2022.103889. Epub ahead of print. PMID: 36343431; PMCID: PMC9574463.


Alcohol sales in Canadian liquor outlets as a predictor of subsequent COVID-19 infection rates: a time-series analysis. 

Stockwell T, Zhao J, Alam F, Churchill S, Shi Y, Naimi T. 

Addiction. 2022 Dec;117(12):3069-3078. doi: 10.1111/add.16011. Epub 2022 Aug 12. PMID: 35913022; PMCID: PMC9538471.


Challenges and opportunities for educating health professionals after the COVID-19 pandemic.

Frenk, Julio, et al. "

The Lancet 400.10362 (2022): 1539-1556.


Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam. 

Giang HT, Duc NQ, Molès JP, Vinh VH, Nagot N, Thanh NTT, Huong DT, Oanh KTH, Khue PM, Mai LS, Trang NT, Ngoc PT, Quillet C, Feelemyer J, Vallo R, Michel L, Jarlais DD, Laureillard D, Rapoud D. 

Int J Drug Policy. 2022 Sep 21;110:103870. doi: 10.1016/j.drugpo.2022.103870. Epub ahead of print. PMID: 36244242; PMCID: PMC9489978.


A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study.

Bužančić I, Pejaković TI, Hadžiabdić MO. 

Pharmacy (Basel). 2022 Sep 23;10(5):120. doi: 10.3390/pharmacy10050120. PMID: 36287441; PMCID: PMC9611451.


Machine Learning Techniques to Explore Clinical Presentations of COVID-19 Disease Severity and to Test the Association with Unhealthy Opioid Use (UOU): Retrospective Cross-sectional Cohort Study. 

Thompson HM, Sharma B, Smith D, Bhalla S, Erondu I, Hazra A, Ilyas Y, Pachwicewicz P, Sheth NK, Chhabra N, Karnik NS, Afshar M. 

JMIR Public Health Surveill. 2022 Oct 18. doi: 10.2196/38158. Epub ahead of print. PMID: 36265163.


The Effect of COVID-19 on QTc Prolongation. 

Alsallamin I, Skomorochow E, Musallam R, Bawwab A, Alsallamin A. 

Cureus. 2022 Oct 3;14(10):e29863. doi: 10.7759/cureus.29863. PMID: 36204258; PMCID: PMC9528850.


Opportunities and Challenges for Professionals in Psychiatry and Mental Health Care Using Digital Technologies During the COVID-19 Pandemic: Systematic Review. 

Kane H, Gourret Baumgart J, El-Hage W, Deloyer J, Maes C, Lebas MC, Marazziti D, Thome J, Fond-Harmant L, Denis F. 

JMIR Hum Factors. 2022 Feb 4;9(1):e30359. doi: 10.2196/30359. PMID: 34736224; PMCID: PMC8820762.


Substance Use From Social Distancing and Isolation By US Nativity During the Time of Covid-19: Cross-Sectional Study. 

Montiel Ishino FA, Villalobos K, Williams F. 

JMIR Public Health Surveill. 2022 Oct 18. doi: 10.2196/38163. Epub ahead of print. PMID: 36265162.


Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium. 

King L, Hayashi K, Genberg B, Choi J, DeBeck K, Kirk G, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ. 

Drug Alcohol Depend. 2022 Oct 6:109654. doi: 10.1016/j.drugalcdep.2022.109654. Epub ahead of print. PMID: 36266158; PMCID: PMC9535877.


Cross-sectional survey of the Mental health and Addictions effects, Service impacts and Care needs of children, youth and families during the COVID-19 pandemic: the COVID-19 MASC study protocol. 

Markoulakis R, Khalid M, Da Silva A, Kodeeswaran S, Sinyor M, Cheung A, Redelmeier D, MacKillop J, Scarpitti M, Laird H, Foot J, Levitt A. 

BMJ Open. 2022 Oct 26;12(10):e066190. doi: 10.1136/bmjopen-2022-066190. PMID: 36288837; PMCID: PMC9615177.


Impact of Social Isolation during the COVID-19 Pandemic on Mental Health, Substance Use, and Homelessness: Qualitative Interviews with Behavioral Health Providers.

Jeffers A, Meehan AA, Barker J, Asher A, Montgomery MP, Bautista G, Ray CM, Laws RL, Fields VL, Radhakrishnan L, Cha S, Christensen A, Dupervil B, Verlenden JV, Cassell CH, Boyer A, DiPietro B, Cary M, Yang M, Mosites E, Marcus R. 

Int J Environ Res Public Health. 2022 Sep 25;19(19):12120. doi: 10.3390/ijerph191912120. PMID: 36231422; PMCID: PMC9566547.


Have Deaths of Despair Risen during the COVID-19 Pandemic? A Systematic Review. 

Rahimi-Ardabili H, Feng X, Nguyen PY, Astell-Burt T. 

Int J Environ Res Public Health. 2022 Oct 7;19(19):12835. doi: 10.3390/ijerph191912835. PMID: 36232135; PMCID: PMC9564909.


Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV. 

Schaaf REA, Verburgh ML, Boyd A, Wit FW, Nieuwkerk PT, Schim van der Loeff MF, Reiss P; AGEhIV Study Group. 

J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):261-268. doi: 10.1097/QAI.0000000000003055. Epub 2022 Jul 13. PMID: 36252241; PMCID: PMC9561239.


UK. A post-pandemic spike in substance use amongst young people & barriers to accessing support

Following the ending of Covid-19 restrictions, illegal drug use has soared among young people. 1 in 3 young people have used an illegal drug in the past 12 months, and yet it still remains a taboo topic in our society.

1 in 5 substance users now take drugs or alcohol to escape problems in their life, and growing numbers experience challenges due to substance use and are in need of support. However, societal attitudes connected to substance use and addiction, lack of awareness of services available or belief that there are no suitable services available prevent many from seeking help. As a result, hundreds of thousands of young people are suffering in silence rather than reaching out for support. 

Moreover, official figures show that drug-related deaths have been rising across the UK population, reaching their peak in 2021. In England and Wales alone, there were 4,859 drug-related deaths, representing a 6.2% increase from the figures in 2020. (The Mix, UK, Oktober 2020)


Naltrexone: Addiction Drug Shows Promise Lifting Long COVID Brain Fog, Fatigue

(Medscape, USA, 18.10.2022)


Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. 

Pitt B, Tate AM, Gluck D, Rosenson RS, Goonewardena SN. 

Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):402-405. doi: 10.1093/ehjcvp/pvac014. PMID: 35179184; PMCID: PMC8903502.


Post-COVID-Syndrom (PCS)

Der Vorstand der Bundesärztekammer hat in seiner außerordentlichen Sitzung vom 23.9.2022 auf Empfehlung des Wissenschaftlichen Beirats diese Stellungnahme beraten und beschlossen. (BÄK, 23.09.2022)



For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic. 

Rogers JM, Smith KE, Schriefer D, Epstein DH. 

Subst Abuse. 2022 Sep 28;16:11782218221123977. doi: 10.1177/11782218221123977. PMID: 36199697; PMCID: PMC9527987.


Increased alcohol use, heavy episodic drinking, and suicide ideation during the COVID-19 pandemic in Canada. 

Varin M, Liu L, Gabrys R, Gariepy G, MacEachern KH, Weeks M. 

Can J Public Health. 2022 Oct 6:1–11. doi: 10.17269/s41997-022-00689-7. Epub ahead of print. PMID: 36203029; PMCID: PMC9540056.


Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs. 

Traeger MW, van Santen DK, Sacks-Davis R, Asselin J, Carter A, Doyle JS, Pedrana A, Wilkinson AL, Howell J, Thatcher R, Didlick J, Donovan B, Guy R, Hellard ME, Stoové MA; Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS). 

J Viral Hepat. 2022 Oct;29(10):908-918. doi: 10.1111/jvh.13723. Epub 2022 Jul 5. PMID: 35722739; PMCID: PMC9350356.